Stem Cells http://www.peprotech.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lebkowski, J. S.
Right arrow Articles by Okarma, T. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lebkowski, J. S.
Right arrow Articles by Okarma, T. B.

Stem Cells, Vol 13, 607-612, Copyright © 1995 by AlphaMed Press


REVIEWS

Serum-free culture of hematopoietic stem cells: a review

JS Lebkowski, LR Schain and TB Okarma
Applied Immune Sciences, Inc., Santa Clara, California 95054-1114, USA.

The development of serum-free systems for the maintenance and expansion of both primitive and committed hematopoietic progenitors has numerous applications in both basic and clinical research. Many different media have been tested and refined over the years, and current formulations now yield results similar to those observed with fetal bovine serum- based medias. Using these serum-free culture systems, the impact of the cell microenvironment and individual growth factors on primitive and maturing stem cells have both been studied. The utility of progenitor populations expanded ex vivo under serum-free conditions is under investigation.


This article has been cited by other articles:


Home page
Stem CellsHome page
E. Balducci, G. Azzarello, M. T. Valenti, G. M. Capuzzo, G. L. Pappagallo, I. Pilotti, S. Ausoni, M. Bari, F. Rosetti, D. Sartori, et al.
The Impact of Progenitor Enrichment, Serum, and Cytokines on the Ex Vivo Expansion of Mobilized Peripheral Blood Stem Cells: A Controlled Trial
Stem Cells, January 1, 2003; 21(1): 33 - 40.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. J.G. Southcott, M. J.A. Tanner, and D. J. Anstee
The Expression of Human Blood Group Antigens During Erythropoiesis in a Cell Culture System
Blood, June 15, 1999; 93(12): 4425 - 4435.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Z. Ratajczak, J. Ratajczak, B. Machalinski, R. Mick, and A. M. Gewirtz
In Vitro and In Vivo Evidence That Ex Vivo Cytokine Priming of Donor Marrow Cells May Ameliorate Posttransplant Thrombocytopenia
Blood, January 1, 1998; 91(1): 353 - 359.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
J. Birkmann, S. Oez, M. Smetak, G. Kaiser, H. Kappauf, and W. M. Gallmeier
Effects of Recombinant Human Thrombopoietin Alone and in Combination with Erythropoietin and Early-Acting Cytokines on Human Mobilized Purified CD34+ Progenitor Cells Cultured in Serum-Depleted Medium
Stem Cells, January 1, 1997; 15(1): 18 - 32.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.peprotech.com/
Copyright © 1995 by AlphaMed Press.